Translational medicine

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Translational medicine (often referred to as translational science, of which it is a form) is defined by the European Society for Translational Medicine (EUSTM) as an interdisciplinary branch of the biomedical field supported by three main pillars: benchside, bedside and community.[1] The goal of TM is to combine disciplines, resources, expertise, and techniques within these pillars to promote enhancements in prevention, diagnosis, and therapies. Accordingly, TM is a highly interdisciplinary field, the primary goal of which is to coalesce assets of various natures within the individual pillars in order to improve the global healthcare system significantly.[2]

Translational medicine is a rapidly growing discipline in biomedical research and aims to expedite the discovery of new diagnostic tools and treatments by using a multi-disciplinary, highly collaborative, "bench-to-bedside" approach.[3] Within public health, translational medicine is focused on ensuring that proven strategies for disease treatment and prevention are actually implemented within the community. One prevalent description of translational medicine, first introduced by the Institute of Medicine's Clinical Research Roundtable, highlights two roadblocks (i.e., distinct areas in need of improvement): the first translational block (T1) prevents basic research findings from being tested in a clinical setting; the second translational block (T2) prevents proven interventions from becoming standard practice.[4]

The National Institutes of Health (NIH) has made a major push to fund translational medicine, especially within biomedical research, with a focus on cross-functional collaborations (e.g., between researchers and clinicians); leveraging new technology and data analysis tools; and increasing the speed at which new treatments reach patients. In December 2011, The National Center for Advancing Translational Science (NCATS) was established within the NIH to "transform the translational science process so that new treatments and cures for disease can be delivered to patients faster." [5] The Clinical and Translational Science Awards, established in 2006 and now funded by NCATS, supports 60 centers across the country that provide "academic homes for translational sciences and supporting research resources needed by local and national research communities." [6] According to an article published in 2007 in Science Career Magazine, in 2007 to 2013 the European Commission targeted a majority of its €6 billion budget for health research to further translational medicine.[7]

Training and education[edit]

In recent years, a number of educational programs have emerged to provide professional training in the skills necessary for successfully translating research into improved clinical outcomes. These programs go by various names (including Master of Translational Medicine and Master of Science in Bioinnovation). Many such programs emerge from bioengineering departments, often in collaboration with clinical departments.

Master and PhD programs[edit]

The University of Edinburgh has been running an MSc in Translational Medicine program since 2007. It is a 3-year online distance learning programme aimed at the working health professional.[8]

Aalborg University Denmark has been running a master's degree in translational medicine since 2009.

A master's degree programme in translational medicine was started at the University of Helsinki in 2010.

In 2010, UC Berkeley and UC San Francisco used a founding grant from Andy Grove [9] to launch a joint program that became the Master of Translational Medicine. The program links the Bioengineering department at Berkeley with the Bioengineering and Therapeutic Science department at UCSF to give students a one-year experience in fostering medical innovation.

Cedars-Sinai Medical Center in Los Angeles, California was accredited in 2012 for a doctoral program in Biomedical Science and Translational Medicine. The PhD program focuses on biomedical and clinical research that relate directly to developing new therapies for patients.[10]

In Fall 2015, The City College of New York established a master in translational medicine program.[11] A partnership between The Grove School of Engineering and the Sophie Davis School for Biomedical Education/CUNY School of Medicine, this program provides scientists, engineers, and pre-med students with training in product design, intellectual property, regulatory affairs, and medical ethics over 3 semesters.

Imperial College London,University College London,Oxford and Cambridge Universities run post-graduate courses in Translational Medicine too.

Newcastle University and Queen's University Belfast also offer MRes courses in Translational Medicine.[12]

Tulane University has a PhD program in Bio-Innovation to foster design and implementation of innovative biomedical technologies.

Diplomas and courses[edit]

Academy of Translational Medicine Professionals (ATMP) offers a regular professional certification course 'Understanding Translational Medicine Tools and Techniques'' [13]

James Lind Institute has been conducting a Postgraduate Diploma in Translational Medicine since early 2013. The program has been supported by the Universiti Sains Malaysia.[14]

The University of Southern California (USC) School of Pharmacy offers a course in Translational Medicine.

International organizations[edit]

European Society for Translational Medicine (EUSTM)[edit]

The European Society for Translational Medicine (EUSTM) is a global non-profit and neutral healthcare organization whose principal objective is to enhance world-wide healthcare by using translational medicine approaches, resources and expertise.[15] The society facilitates cooperation and interaction among clinicians, scientists, academia, industry, governments, funding and regulatory agencies, investors and policy makers in order to develop and deliver high quality translational medicine programs and initiatives with overall aim to enhance the healthcare of global population. The society׳s goal is to enhance research and development of novel and affordable diagnostic tools and treatments for the clinical disorders affecting global population.[16]

The society provides an annual platform in the form of global congresses where global key opinion leaders, scientists from bench side, public health professionals, clinicians from bedside and industry professionals gather and take part in the panel discussions and scientific sessions on latest updates and developments in translational medicine field including biomarkers, omics sciences, cellular and molecular biology, data mining & management, precision medicine & companion diagnostics, disease modelling, vaccines and community healthcare. [17]

Academy of Translational Medicine Professionals (ATMP)[edit]

Academy of Translational Medicine Professionals (ATMP) is working to advance the ongoing knowledge and skills for clinicians and scientific professionals at all levels. Academy’s high quality, standard and ethical training and educational programs ensure that all clinical and scientific professionals achieve excellence in their respective fields. Programs are accredited by the European Society for Translational Medicine (EUSTM).[18]

Fellowship program (FAcadTM)[edit]

Academy of Translational Medicine Professionals (ATMP) offers fellowship program which is open to highly experienced professionals who have a record of significant achievements in benchside, bedside or community health fields.[19]

References[edit]

  1. ^ "Translational Medicine definition by the European Society for Translational Medicine". New Horizons in Translational Medicine. Volume 2 (Issue 3): 86–88. 11 December 2014. doi:10.1016/j.nhtm.2014.12.002
  2. ^ "Translational Medicine definition by the European Society for Translational Medicine". New Horizons in Translational Medicine. Volume 2 (Issue 3): 86–88. 11 December 2014. doi:10.1016/j.nhtm.2014.12.002
  3. ^ Woolf, Stephen H. (January 2008), "The Meaning of Translational Research and Why It Matters" (PDF), JAMA, 299 (2): 211–13, doi:10.1001/jama.2007.26, PMID 18182604 
  4. ^ Woolf, Stephen H. (January 2008), "The Meaning of Translational Research and Why It Matters" (PDF), JAMA, 299 (2): 211–13, doi:10.1001/jama.2007.26, PMID 18182604 
  5. ^ http://www.ncats.nih.gov/about/about.html
  6. ^ http://www.ncats.nih.gov/research/cts/ctsa/about/about.html
  7. ^ http://sciencecareers.sciencemag.org/career_magazine/previous_issues/articles/2007_08_17/caredit.a0700119
  8. ^ http://careers.bmj.com/careers/advice/view-article.html?id=2607"; Online learning in translational medicine
  9. ^ http://bits.blogs.nytimes.com/2010/05/17/grove-backs-an-engineers-approach-to-medicine/?ref=technology Grove backs an engineer's approach to medicine"; New York Times blog
  10. ^ "cedars-sinai". 
  11. ^ http://www.ccnymtm.org"
  12. ^ http://www.ncl.ac.uk/postgraduate/courses/translational-medicine-therapeutics-mres.html#profile
  13. ^ "Professional Certification Course". EUSTM. Retrieved 2016-01-19. 
  14. ^ "JLI Translational Medicine". 
  15. ^ Cohrs, Randall J.; Martin, Tyler; Ghahramani, Parviz; Bidaut, Luc; Higgins, Paul J.; Shahzad, Aamir. "Translational Medicine definition by the European Society for Translational Medicine". New Horizons in Translational Medicine. 2 (3): 86–88. doi:10.1016/j.nhtm.2014.12.002. 
  16. ^ Cohrs, Randall J.; Martin, Tyler; Ghahramani, Parviz; Bidaut, Luc; Higgins, Paul J.; Shahzad, Aamir. "Translational Medicine definition by the European Society for Translational Medicine". New Horizons in Translational Medicine. 2 (3): 86–88. doi:10.1016/j.nhtm.2014.12.002. 
  17. ^ "Abstracts: 3rd Annual Congress of the European Society for Translational Medicine (EUSTM-2015) 1–4 September, 2015, Vienna, Austria.". New Horizons in Translational Medicine. 2 (6-7): 175–194. doi:10.1016/j.nhtm.2015.12.001. 
  18. ^ Cohrs, Randall J.; Martin, Tyler; Ghahramani, Parviz; Bidaut, Luc; Higgins, Paul J.; Shahzad, Aamir. "Translational Medicine definition by the European Society for Translational Medicine". New Horizons in Translational Medicine. 2 (3): 86–88. doi:10.1016/j.nhtm.2014.12.002. 
  19. ^ "Fellowship (FAcadTM)". EUSTM. Retrieved 2016-01-19. 

External links[edit]